![Floris van Delft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Floris van Delft is the founder of SynAffix BV, where he holds the title of Chief Scientific Officer since 2010.
He previously worked as an Associate Professor at Radboud University Nijmegen.
Dr. van Delft obtained a graduate and doctorate degree from the University of Leiden.
Postes actifs de Floris van Delft
| Sociétés | Poste | Début |
|---|---|---|
SynAffix BV
 SynAffix BV BiotechnologyHealth Technology Develops antibody-drug conjugates | Fondateur | 01/01/2010 |
Anciens postes connus de Floris van Delft
| Sociétés | Poste | Fin |
|---|---|---|
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Floris van Delft
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SynAffix BV
SynAffix BV BiotechnologyHealth Technology Develops antibody-drug conjugates | Health Technology |
